Medtronic To Compare Endeavor To Boston Scientific’s Taxus In New Trial

Medtronic's addition of a fourth clinical trial to support its Endeavor AVT-578-eluting coronary stent is unlikely to delay the PMA filing past the previously stated target of summer 2005, the company asserts